Matthew W. Martin,
John Newcomb,
Joseph J. Nunes,
Christina Boucher,
Lilly Chai,
Linda F. Epstein,
Theodore Faust,
Sylvia Flores,
Paul Gallant,
Anu Gore,
Yan Gu,
Faye Hsieh,
Xin Huang,
Joseph L. Kim,
Scot Middleton,
Kurt Morgenstern,
Antonio Oliveira-dos-Santos,
Vinod F. Patel,
David Powers,
Paul Rose,
Yanyan Tudor,
Susan M. Turci,
Andrew A. Welcher,
Debra Zack,
Huilin Zhao,
Li Zhu,
Xiaotian Zhu,
Chiara Ghiron,
Monika Ermann,
David Johnston,
Carl-Gustaf Pierre Saluste,
- Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. Martin, M.W., Newcomb, J., Nunes, J.J., Boucher, C., Chai, L., Epstein, L.F., Faust, T., Flores, S., Gallant, P., Gore, A., Gu, Y., Hsieh, F., Huang, X., Kim, J.L., Middleton, S., Morgenstern, K., Oliveira-dos-Santos, A., Patel, V.F., Powers, D., Rose, P., Tudor, Y., Turci, S.M., Welcher, A.A., Zack, D., Zhao, H., Zhu, L., Zhu, X., Ghiron, C., Ermann, M., Johnston, D., Saluste, C.G. J. Med. Chem. (2008)